Importantly, intrarenal complement gene expression (C1R, C1QB, C6, C9, C5, MASP2) predicts nonresponse to induction therapy (40), alluding to the potential pathogenic role of intrarenal complement gene expression in chronic kidney disease. The gene discussed is MASP2; the disease is chronic kidney disease.